In asthma, IL17 is suspected to stimulate epithelial cells and fibroblasts to release neutrophil chemoattractants and granulocyte–macrophage colony-stimulating factor, resulting in neutrophilic infiltration in the lungs. This evidence concerns the gene IL17A and asthma.